Single Project

IMMUNE Pharmaceuticals, Inc. (NASDAQ: IMNP)


Project Description

Dr. Daniel Teper, CEO of IMMUNE Pharmaceuticals, Inc. (NASDAQ: IMNP)¬†Interviewed Live on Clear Channel Business Talk Radio’s ‘The Traders Network Show’

Press Release Link: http://1800publicrelations.com/2014/12/10/immune-pharmaceuticals-inc/

For more information about Performance Based PR services please contact:

Matt Bird

646.401.4499

matt.bird@1800pr.com

or

support@1800pr.com


Visit Our BlogVisit Our BlogVisit Our Blog